17-ketosteroids has been researched along with Laryngeal-Neoplasms* in 5 studies
5 other study(ies) available for 17-ketosteroids and Laryngeal-Neoplasms
Article | Year |
---|---|
Urinary androgen- and estrogen excretion in men with pachydermia laryngis and cancer of the larynx.
Considering the larynx as a hormone dependent secondary sex characteristic has previously led to successful antiandrogentherapy of pachydermia of the vocal cords, which may constitute a precancerous state. As a first step to further evaluate the endocrine state of patients with precancerous lesions or cancer of the larynx, the urinary excretion of 17-hydroxysteroids, 17-ketosteroids, testosterone and estrogens has been determined in male patients with pachydermia laryngis (n = 15) or cancer of the larynx (n = 20) as compared to controls with different other otorhino-laryngological affections (n = 20). No difference between groups was found in 17-hydroxysteroids and no significant difference in 17-ketosteroid excretion. The pachydermia group as a whole showed significantly increased levels of testosterone (p = 0.01) and estrogen (p = 0.04) of 64.6 +/- 39.9 microgram/24 hr testosterone versus 34.7 +/- 19.3 microgram/24 hr in controls and 31.7 +/- 16 microgram/24 hr in laryngeal cancer and 277 +/- 14.8 microgram/24 hr total estrogens versus 19.1 +/- 12 microgram/24 hr and 17.8 +/- 8.1 microgram/24 hr respectively. These data further support the idea of hormonal factors playing an important role in the pathogenesis of pachydermia and thus possibly cancer of the larynx. So far, however, they do not permit definite conclusions on the pathogenetic mechanisms involved. Topics: 17-Ketosteroids; Adult; Aged; Estrogens; Humans; Hydroxysteroids; Laryngeal Diseases; Laryngeal Neoplasms; Male; Middle Aged; Testosterone | 1979 |
Anti-androgen-therapy in pachydermia of the female larynx--a new therapeutic possibility.
Case-report about a 56 year old white female patient with pachydermia laryngis and hirsutism, successfully treated with cyproterone-acetate, a testosterone antagonist. The significance of androgenic hormones for the development of epithelial changes in the female larynx is emphasized. The administration of antiandrogenic substances as a new therapeutic measure is discussed. Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Cyproterone; Estrogens; Female; Hirsutism; Humans; Laryngeal Neoplasms; Middle Aged; Precancerous Conditions; Testosterone; Vocal Cords | 1977 |
[Female laryngeal carcinoma and sexual hormones].
Topics: 17-Ketosteroids; Adult; Aged; Androgens; Estrogens; Female; Humans; Laryngeal Neoplasms; Menstruation; Middle Aged | 1969 |
[On a functional examination of the adrenal cortex for the purpose of radiotherapy].
Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Bone Neoplasms; Chromatography; Dehydroepiandrosterone; Female; Hodgkin Disease; Humans; Injections, Intramuscular; Laryngeal Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasms; Pituitary-Adrenal System; Polarography; Prostatic Neoplasms; Tibia; Uterine Cervical Neoplasms | 1967 |
[Studies on the endocrine function of the male gonad in laryngeal cancer].
Topics: 17-Ketosteroids; Adult; Aged; Estrogens; Humans; Laryngeal Neoplasms; Male; Middle Aged; Urine | 1966 |